GTHX
G1 Therapeutics Inc
Price:  
7.15 
USD
Volume:  
1,788,450.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GTHX WACC - Weighted Average Cost of Capital

The WACC of G1 Therapeutics Inc (GTHX) is 7.3%.

The Cost of Equity of G1 Therapeutics Inc (GTHX) is 7.35%.
The Cost of Debt of G1 Therapeutics Inc (GTHX) is 7.00%.

Range Selected
Cost of equity 6.00% - 8.70% 7.35%
Tax rate 1.00% - 1.30% 1.15%
Cost of debt 7.00% - 7.00% 7.00%
WACC 6.1% - 8.5% 7.3%
WACC

GTHX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.46 0.68
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.00% 8.70%
Tax rate 1.00% 1.30%
Debt/Equity ratio 0.14 0.14
Cost of debt 7.00% 7.00%
After-tax WACC 6.1% 8.5%
Selected WACC 7.3%